Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Evogene Ltd. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 29 | 28 | −1 |
| Shares | 4.05M | 3.93M | −123.4K (−3.0%) |
| Value | $3.04M | $2.55M | −$483.2K (−15.9%) |
New holders (3)
Institutions that held Evogene Ltd. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 13,145 | $8.55K | 0.00% |
| Cypress Capital, LLC | 400 | $260 | 0.00% |
| Coppell Advisory Solutions LLC | 27 | $18 | 0.00% |
Sold out (4)
Institutions that held Evogene Ltd. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Virtu Financial LLC | 11,524 | $9.00K |
| Malaga Cove Capital, LLC | 12,000 | $9.00K |
| Commonwealth Equity Services, LLC | 11,089 | $8.00K |
| Group One Trading, L.P. | 126 | $93 |